FibroGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Thane Wettig

CEOThane Wettig

Employees

225

Employees225

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

225

Employees225

FGEN Key Statistics

Market cap

32.09M

Market cap32.09M

Price-Earnings ratio

-3.14

Price-Earnings ratio-3.14

Dividend yield

—

Dividend yield—

Average volume

724.49K

Average volume724.49K

High today

$0.3299

High today$0.3299

Low today

$0.311

Low today$0.311

Open price

$0.3245

Open price$0.3245

Volume

557.41K

Volume557.41K

52 Week high

$1.53

52 Week high$1.53

52 Week low

$0.18

52 Week low$0.18

People also own

Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.